The mRNA-based reprogramming of fibroblasts from a SOD1E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007

Stem Cell Res. 2020 Jan:42:101701. doi: 10.1016/j.scr.2020.101701. Epub 2020 Jan 16.

Abstract

Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1E101G mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / genetics*
  • Cell Line
  • Fibroblasts / metabolism*
  • Humans
  • Kruppel-Like Factor 4
  • RNA, Messenger / metabolism
  • Superoxide Dismutase-1 / genetics*

Substances

  • KLF4 protein, human
  • Kruppel-Like Factor 4
  • RNA, Messenger
  • SOD1 protein, human
  • Superoxide Dismutase-1